1. Construction of Durvalumab/carbon nanotube/PEI/aptamer-siRNA chimera for the immunotherapy of hepatocellular carcinoma. (1st March 2022) Authors: Qiang, Niu; Wei, Lv; Tao, Yan; Jin, Wang; Bin, Yan; DingHua, Zhou Journal: Biomedical materials Issue: Volume 17:Number 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗